Aerie Pharmaceuticals Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

53,554

Value ($000)

810

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	810	0.0%	53,554	9/30/2022
2022 Q2	8/12/2022	384	0.0%	51,244	6/30/2022
2022 Q1	5/16/2022	499	0.0%	54,793	3/31/2022
2021 Q4	2/14/2022	385	0.0%	54,793	12/31/2021
2021 Q3	11/15/2021	625	0.0%	54,793	9/30/2021
2021 Q2	8/16/2021	876	0.0%	54,726	6/30/2021
2021 Q1	5/14/2021	752	0.0%	42,076	3/31/2021
2020 Q4	3/1/2021	568	0.0%	42,076	12/31/2020
2020 Q3	11/13/2020	495	0.0%	42,076	9/30/2020
2020 Q2	8/14/2020	638	0.0%	43,244	6/30/2020
2020 Q1	5/15/2020	563	0.0%	41,722	3/31/2020
2019 Q4	2/14/2020	922	0.0%	38,136	12/31/2019